Darwin Global Management, Ltd.

SEC CIK: 0001839209
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ALLO holding history

Allogene Therapeutics, Inc. in every 13F filed by Darwin Global Management, Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALLO overview All 13F holders of ALLO Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2025

Holdings of ALLO by Darwin Global Management, Ltd., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−10,479,791−100.0%	Sold out	Holders
Q2 2025	10,479,791	$12.4M	0.5%	+30,000+0.3%	Added	Holders
Q1 2025	10,449,791	$16.2M	1.1%	+10,449,791	New	Holders